Valuation of Physician Samples for Excise Duty Remanded for Re-quantification The appeal regarding the valuation of physician samples for excise duty purposes between 25.4.2005 to 31.10.2005 is remanded for re-quantification of duty ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Valuation of Physician Samples for Excise Duty Remanded for Re-quantification
The appeal regarding the valuation of physician samples for excise duty purposes between 25.4.2005 to 31.10.2005 is remanded for re-quantification of duty demands. The Tribunal directs compliance with CAS-4 standards and appropriate valuation principles, emphasizing transaction value for samples sold to brand owners and CAS-4 standards for job work clearances.
Issues: Valuation of physician samples for excise duty - Application of CBEC Circular - Interpretation of transaction value - Distinction between free distribution and sale to brand owners - Valuation for job work basis - Compliance with CAS-4 standards - Re-quantification of duty demands.
Analysis:
Valuation of Physician Samples: The appeal concerns the valuation of physician samples for excise duty purposes, focusing on clearances made by the assessee between 25.4.2005 to 31.10.2005. The dispute revolves around the treatment of physician samples sold to brand owners and those manufactured and cleared for free distribution to doctors. The Revenue contends that valuation should be done in accordance with CBEC Circular No.813/10/2005-CX, requiring proportional valuation based on the value of trade packs of the same medicine. The Revenue relies on precedents like the Hon'ble Bombay High Court's decision and other cases to support their stance.
Interpretation of Transaction Value: The core issue is the interpretation of transaction value for physician samples. The Revenue argues that the value should be determined as per the CBEC Circular, emphasizing the application of Rule 4 of the Valuation Rules. However, the respondent's representative distinguishes the present case from the cited judgments, highlighting that the samples were not distributed free but sold to brand owners, necessitating valuation based on transaction value. The respondent cites previous tribunal decisions and the apex court's ruling in Sun Pharmaceuticals Industries Ltd. to support their position.
Compliance with CAS-4 Standards: The respondent's compliance with CAS-4 standards for valuation is a crucial aspect. The Tribunal acknowledges the respondent's practice of paying duty based on CAS-4 standards for physician samples manufactured on a job work basis. The valuation for such samples is to be done in line with the principles of costing under CAS-4, as supported by the Ujagar Prints case. The Tribunal directs a re-quantification of the duty demands for clearances made as a job worker to ensure compliance with CAS-4 certification.
Re-Quantification of Duty Demands: The Tribunal remands the matter back to the original authority for re-quantification of the duty demands. It notes the lack of clarity in the basis for arriving at the demands and the absence of supporting worksheets in the records. The re-quantification is to be conducted in alignment with the discussions and principles outlined in the judgment, emphasizing the acceptance of transaction value for samples sold to brand owners and CAS-4 standards for job work clearances.
In conclusion, the appeal is disposed of by way of remand for re-quantification of duty demands, ensuring compliance with CAS-4 standards and appropriate valuation principles for physician samples based on transaction value and job work basis.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.